Advisory Board October 20, 2025
Johnson & Johnson (J&J) recently announced plans to separate its orthopedics business to enhance its focus on strategy and operations, in today’s bite-sized hospital and health industry news from California, New Jersey, and South Carolina.
- California: Skye Bioscience has hit a wall with its experimental obesity drug after it failed to help patients lose a significant amount of weight in a mid-stage study. The drug, which is called nimacimab, is an antibody that blocks CB1 receptors. In the study, patients who were on nimacimab lost an average of 1.5% of their body weight over 26 weeks, which was not statistically different than those taking a placebo. According to Skye, its preliminary analysis showed lower-than-expected drug exposure, which suggests...
Today's Sponsors
Today's Sponsor
Topics: Medical Devices